Krishna Mohan Chauhan

Krishna Mohan Chauhan is an experienced analytical development virologist currently working at ABL Inc. since February 2023, focusing on R&D, test method development, and scientific innovation in vaccine and gene therapy. Previously, Krishna served at Catalent Pharma Solutions, where responsibilities included validating gene therapy products through advanced molecular techniques and developing standard test methods under cGMP guidelines. With a solid academic foundation, Krishna earned a PhD in Biochemistry with a focus on Cancer Biology from the University of Mississippi Medical Center and has held various research positions at institutions including the University of Maryland Baltimore County and Oregon Health & Science University, contributing to significant advancements in cancer research and metabolic enzyme functions.